Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs

T. M. MacDonald, S. V. Morant, J. L. Goldstein, T. A. Burke, D. Pettitt

    Research output: Contribution to journalArticlepeer-review

    81 Citations (Scopus)

    Abstract

    Although clinical trial results suggest that meloxicam has less gastrointestinal toxicity than most other non-steroidal anti-inflammatory drugs (NSAIDs), in practice it has been associated with a large number of yellow card reports of gastrointestinal complications.
    Original languageEnglish
    Pages (from-to)1265-1270
    Number of pages6
    JournalGut
    Volume52
    Issue number9
    DOIs
    Publication statusPublished - 2003

    Fingerprint Dive into the research topics of 'Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs'. Together they form a unique fingerprint.

    Cite this